Form 4: HCA Healthcare CEO Samuel Hazen Reports Changes in Beneficial Ownership

Samuel Hazen, CEO of HCA Healthcare, filed a Form 4 detailing changes in his beneficial ownership of company stock due to gift transactions.

Summary

• On August 6, 2024, Samuel Hazen, CEO of HCA Healthcare, reported changes in his beneficial ownership of HCA stock.
• The transactions involved the gifting of common stock, resulting in both disposals and acquisitions due to direct and indirect ownership changes.
• Specifically, 7,115 shares were disposed of and acquired directly, while 12,084 shares were disposed of and acquired directly.
• Additionally, 3,012 shares were disposed of and acquired directly.
• On August 8, 2024, 7,115 shares were disposed of and acquired indirectly by spouse.
• Following these transactions, Hazen directly owns 78,296 shares of common stock.
• Hazen also indirectly owns shares through his spouse (14,979), the HD Trust (813,320), an LP (163,918), the 2022 GRAT (250,000), the 2024 GRAT, the 2023 GST Trust (16,731), and the 2023 Trust (3,012).
• The filing also includes a Limited Power of Attorney, effective April 14, 2008, authorizing Robert A. Waterman, John M. Franck II, and Natalie Harrison Cline to handle SEC reporting obligations on Hazen's behalf.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to changes in beneficial ownership. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The filing provides transparency to shareholders regarding the CEO's transactions in company stock.
• It assures stakeholders that insider transactions are being properly disclosed.

Key Dates